SCYL1 and breast carcinoma: To further characterize the biological functions of SCYL1 in the progression of breast cancer, lentiviral-mediated shRNAs were used to silence endogenous SCYL1expression in breast cancer cell lines, including MDA-MB-231 and MCF-7.